NO20025186L - Fremgangsmåte for syntese av en ecteinascidinforbindelse - Google Patents

Fremgangsmåte for syntese av en ecteinascidinforbindelse

Info

Publication number: NO20025186L
Authority: NO; Norway
Prior art keywords: synthesis; ecteinascidin compound; ecteinascidin; compound
Prior art date: 1999-05-14

Application number

NO20025186A

Other languages

English (en)

Other versions

NO328301B1 (no

NO20025186D0 (no

Inventor

Carmen Cuevas

Marta Perez

Andres Francesch

Carolina Fernandez

Jose Luis Chicharro

Pilar Gallego

Maria Zarzuelo

Ignacio Manzanares

Maria Jesus Martin

Simon Munt

Original Assignee

Pharma Mar Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-14

Filing date

2002-10-29

Publication date

2003-01-14

1999-05-14 Priority claimed from GBGB9911345.8A external-priority patent/GB9911345D0/en

1999-08-02 Priority claimed from GBGB9918178.6A external-priority patent/GB9918178D0/en

1999-10-06 Priority claimed from GBGB9923632.5A external-priority patent/GB9923632D0/en

2000-01-17 Priority claimed from GB0001063A external-priority patent/GB0001063D0/en

2002-10-29 Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa

2002-10-29 Publication of NO20025186D0 publication Critical patent/NO20025186D0/no

2003-01-14 Publication of NO20025186L publication Critical patent/NO20025186L/no

2010-01-25 Publication of NO328301B1 publication Critical patent/NO328301B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20025186A 1999-05-14 2002-10-29 Fremgangsmate for syntese av en ecteinascidinforbindelse NO328301B1 (no)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
GBGB9911345.8A GB9911345D0 (no)	1999-05-14	1999-05-14
GBGB9918178.6A GB9918178D0 (en)	2000-05-15	1999-08-02	Synthetic methods
GBGB9923632.5A GB9923632D0 (en)	1999-10-06	1999-10-06	Hemisynthetic process towards ecteinascidin and phtalscidin compounds
GB0001063A GB0001063D0 (en)	2000-01-17	2000-01-17	Hemisynthetic process towards ecteinascidin and phtalascidin
PCT/GB2000/001852 WO2000069862A2 (en)	1999-05-14	2000-05-15	Hemisynthetic method and intermediates thereof
PCT/GB2001/002120 WO2001087895A1 (en)	1999-05-14	2001-05-15	Synthetic process for the manufacture of an ecteinaschidin compound

Publications (3)

Publication Number	Publication Date
NO20025186D0 NO20025186D0 (no)	2002-10-29
NO20025186L true NO20025186L (no)	2003-01-14
NO328301B1 NO328301B1 (no)	2010-01-25

Family

ID=42632476

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20015547A NO322016B1 (no)	1999-05-14	2001-11-13	Anvendelse av utgangsmaterialer,fremgangsmate for hemisyntese av forbindelser og nye forbindelser
NO20025186A NO328301B1 (no)	1999-05-14	2002-10-29	Fremgangsmate for syntese av en ecteinascidinforbindelse

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO20015547A NO322016B1 (no)	1999-05-14	2001-11-13	Anvendelse av utgangsmaterialer,fremgangsmate for hemisyntese av forbindelser og nye forbindelser

Country Status (29)

Country	Link
US (3)	US7241892B1 (no)
EP (1)	EP1185536B1 (no)
JP (1)	JP4445136B2 (no)
KR (1)	KR100834601B1 (no)
CN (3)	CN1229382C (no)
AR (1)	AR035842A1 (no)
AT (1)	ATE283273T1 (no)
AU (2)	AU775580B2 (no)
BG (1)	BG65896B1 (no)
BR (3)	BRPI0010559B8 (no)
CA (2)	CA2372058C (no)
CY (1)	CY1108095T1 (no)
CZ (3)	CZ303536B6 (no)
DE (1)	DE60016209T2 (no)
DK (1)	DK1185536T3 (no)
ES (2)	ES2233367T3 (no)
HU (1)	HU230646B1 (no)
MX (1)	MXPA01011631A (no)
MY (1)	MY130271A (no)
NO (2)	NO322016B1 (no)
NZ (1)	NZ515424A (no)
PL (1)	PL226890B1 (no)
PT (1)	PT1185536E (no)
RU (1)	RU2237063C9 (no)
SI (2)	SI1185536T1 (no)
SK (2)	SK287835B6 (no)
TR (1)	TR200103273T2 (no)
UA (1)	UA75333C2 (no)
WO (3)	WO2000069862A2 (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE289810T1 (de)	1998-05-11	2005-03-15	Pharma Mar Sa	Ecteinascidinderivate
MY164077A (en)	1999-05-13	2017-11-30	Pharma Mar Sa	Compositions and uses of et743 for treating cancer
MY130271A (en)	1999-05-14	2007-06-29	Pharma Mar Sa	Hemisynthetic method and new compounds
US7919493B2 (en) *	2000-04-12	2011-04-05	Pharma Mar, S.A.	Anititumoral ecteinascidin derivatives
BRPI0110024B8 (pt)	2000-04-12	2021-05-25	Pharma Mar Sa	derivados de ecteinascidina antitumorais, composição farmacêutica que os compreende e uso dos mesmos
JP4942900B2 (ja) *	2000-05-15	2012-05-30	ファルマ・マール・ソシエダード・アノニマ	エクチナサイジン化合物の製造のための合成方法
US7420051B2 (en)	2000-05-15	2008-09-02	Pharma Mar, S.A.	Synthetic process for the manufacture of an ecteinaschidin compound
MXPA02011319A (es)	2000-05-15	2003-06-06	Pharma Mar Sa	Analogos antitumorales de ecteinascidina 743.
AU3956502A (en)	2000-11-03	2002-05-27	Harvard College	Saframycins, analogues and uses thereof
AU2002212499B2 (en) *	2000-11-06	2006-11-02	Pharma Mar, S.A.	Compositions for antitumour treatment containing ecteinascidin 743
GB0117402D0 (en)	2001-07-17	2001-09-05	Pharma Mar Sa	New antitumoral derivatives of et-743
GB0119243D0 (en) *	2001-08-07	2001-10-03	Pharma Mar Sa	Antitumoral analogs of ET-743
US20050004018A1 (en) *	2001-10-19	2005-01-06	Jose Jimeno	Use of antitumoral compound in cancer therapy
GB0202544D0 (en)	2002-02-04	2002-03-20	Pharma Mar Sa	The synthesis of naturally occuring ecteinascidins and related compounds
GB0229793D0 (en) *	2002-12-20	2003-01-29	Pharma Mar Sa	The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
GB0312407D0 (en) *	2003-05-29	2003-07-02	Pharma Mar Sau	Treatment
US7183054B2 (en)	2003-06-03	2007-02-27	President And Fellows Of Harvard College	Assay for identifying biological targets of polynucleotide-binding compounds
GB0324201D0 (en) *	2003-10-15	2003-11-19	Pharma Mar Sau	Improved antitumoral combinations
CA2544320A1 (en)	2003-11-13	2005-06-02	Pharma Mar, S.A.U.	Method of treating cancer using a combination comprising et-743 and 5-fluorouracil
GB0326486D0 (en) *	2003-11-14	2003-12-17	Pharma Mar Sau	Combination treatment
CN1897949A (zh) *	2003-11-14	2007-01-17	马尔药品公司	包含使用et－743和紫杉醇来治疗癌症的联合疗法
US20080242670A2 (en) *	2004-09-29	2008-10-02	Pharma Mar S.A., Sociedad Unipersonal	Anti-Inflammatory Agents
RU2359700C2 (ru) *	2004-10-26	2009-06-27	Фарма Мар С.А., Сосьедад Униперсональ	Пегилированный липосомальный доксорубицин в комбинации с эктеинасцидином 743 (ecteinescidin 743)
WO2006046079A1 (en) *	2004-10-29	2006-05-04	Pharma Mar S.A., Sociedad Unipersonal	Formulations comprising ecteinascidin and a disaccharide
GB0522082D0 (en) *	2005-10-31	2005-12-07	Pharma Mar Sa	Formulations
KR100712667B1 (ko)	2006-04-11	2007-05-02	재단법인서울대학교산학협력재단	신규한 디아자 헤테로고리 유도체 및 그의 고체상 제조방법
GB0708691D0 (en) *	2007-05-04	2007-06-13	Pharma Mar Sa	Anticancer treatments a
US20090076017A1 (en) *	2007-09-15	2009-03-19	Protia, Llc	Deuterium-enriched trabectedin
EP2201141A1 (en) *	2007-10-19	2010-06-30	Pharma Mar S.A.	Prognostic molecular markers for et-743 treatment
MX2010012501A (es) *	2008-05-16	2010-12-20	Pharma Mar Sa	Terapia de combinacion con un alcaloide antitumoral.
RU2519750C2 (ru) *	2008-05-16	2014-06-20	Фарма Мар, С.А.	Способы лечения множественной миеломы
WO2011048210A1 (en)	2009-10-22	2011-04-28	Pharma Mar, S.A.	PDGFR-α AS RESPONSE MARKER FOR PM00104 TREATMENT
CN103038240A (zh) *	2010-05-25	2013-04-10	法马马有限公司	制备海鞘素化合物的合成方法
PL2786754T3 (pl)	2010-11-12	2019-07-31	Pharma Mar S.A.	Leczenie skojarzone inhibitorem mitozy
JOP20190254A1 (ar)	2017-04-27	2019-10-27	Pharma Mar Sa	مركبات مضادة للأورام
CN107739387B (zh) *	2017-10-16	2020-01-03	上海皓元生物医药科技有限公司	一种制备曲贝替定的关键中间体化合物的方法
CN109912629B (zh) *	2017-12-13	2021-12-24	浙江中科创越药业有限公司	天然产物Trabectedin的制备
TWI824043B (zh)	2018-10-25	2023-12-01	西班牙商瑪製藥股份有限公司	藥物抗體共軛物
CN111518110B (zh)	2019-02-01	2023-11-03	博瑞生物医药（苏州）股份有限公司	一种海鞘素化合物及其中间体的制备方法
CN111620792B (zh) *	2019-02-28	2023-01-03	兰州大学	一种n,n-二取代氰基甲酰胺的合成方法
JOP20220118A1 (ar)	2019-11-21	2023-01-30	Pharma Mar Sa	طرق لعلاج سرطان الرئة للخلايا الصغيرة بصيغ من لوربينيكتيدين
CN116217584A (zh) *	2021-12-06	2023-06-06	南通诺泰生物医药技术有限公司	Et743及其中间体的光催化合成方法
CN120641094A (zh) *	2023-01-17	2025-09-12	艾德赛瑞思股份有限公司	海鞘素衍生物抗体药物缀合物
WO2025077996A1 (en)	2023-10-09	2025-04-17	Pharma Mar, S.A.	Synthetic process for the manufacture of ecteinascidin compounds
WO2025233522A1 (en)	2024-05-10	2025-11-13	Pharma Mar, S.A.	Synthetic process for an ecteinascidin

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2461995A1 (fr) *	1979-07-20	1981-02-06	Lcc Cice Cie Europ Compo Elect	Transducteur magneto-electrique pour systeme d'enregistrement magnetique, et systeme d'enregistrement comportant un tel transducteur
JPS59225189A (ja)	1983-06-03	1984-12-18	Shionogi & Co Ltd	キノナミン誘導体およびその製造法
JPS6054386A (ja) *	1983-09-02	1985-03-28	Yoshitomi Pharmaceut Ind Ltd	サフラシン誘導体
JPS6084288A (ja)	1983-10-13	1985-05-13	Shionogi & Co Ltd	シアノキノナミンアセテ−ト類およびその製造法
US5149804A (en)	1990-11-30	1992-09-22	The Board Of Trustees Of The University Of Illinois	Ecteinascidins 736 and 722
EP0309477B1 (en)	1986-06-09	1991-11-06	The Board Of Trustees Of The University Of Illinois	Ecteinascidins 729, 743, 745, 759a, 759b and 770
US5256663A (en)	1986-06-09	1993-10-26	The Board Of Trustees Of The University Of Illinois	Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5089273A (en)	1986-06-09	1992-02-18	Board Of Trustees Of The University Of Illinois	Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5478932A (en)	1993-12-02	1995-12-26	The Board Of Trustees Of The University Of Illinois	Ecteinascidins
SG50747A1 (en) *	1995-08-02	1998-07-20	Tanabe Seiyaku Co	Comptothecin derivatives
US5721362A (en) *	1996-09-18	1998-02-24	President And Fellows Of Harvard College	Process for producing ecteinascidin compounds
US5985876A (en)	1997-04-15	1999-11-16	Univ Illinois	Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
WO1999051238A1 (en)	1998-04-06	1999-10-14	The Board Of Trustees Of The University Of Illinois	Semi-synthetic ecteinascidins
ATE289810T1 (de)	1998-05-11	2005-03-15	Pharma Mar Sa	Ecteinascidinderivate
US6124292A (en)	1998-09-30	2000-09-26	President And Fellows Of Harvard College	Synthetic analogs of ecteinascidin-743
MY130271A (en)	1999-05-14	2007-06-29	Pharma Mar Sa	Hemisynthetic method and new compounds
CA2397597A1 (en)	2000-01-19	2001-07-26	The Trustees Of Columbia University In The City Of New York	Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
BRPI0110024B8 (pt)	2000-04-12	2021-05-25	Pharma Mar Sa	derivados de ecteinascidina antitumorais, composição farmacêutica que os compreende e uso dos mesmos
MXPA02011319A (es)	2000-05-15	2003-06-06	Pharma Mar Sa	Analogos antitumorales de ecteinascidina 743.

2000
- 2000-05-12 MY MYPI20002078A patent/MY130271A/en unknown
- 2000-05-12 AR ARP000102308A patent/AR035842A1/es active IP Right Grant
- 2000-05-15 JP JP2000618279A patent/JP4445136B2/ja not_active Expired - Lifetime
- 2000-05-15 WO PCT/GB2000/001852 patent/WO2000069862A2/en not_active Ceased
- 2000-05-15 US US09/979,404 patent/US7241892B1/en not_active Expired - Lifetime
- 2000-05-15 RU RU2001133386/04A patent/RU2237063C9/ru active
- 2000-05-15 AT AT00927582T patent/ATE283273T1/de active
- 2000-05-15 PT PT00927582T patent/PT1185536E/pt unknown
- 2000-05-15 CZ CZ20014102A patent/CZ303536B6/cs not_active IP Right Cessation
- 2000-05-15 UA UA2001128605A patent/UA75333C2/uk unknown
- 2000-05-15 MX MXPA01011631A patent/MXPA01011631A/es active IP Right Grant
- 2000-05-15 EP EP00927582A patent/EP1185536B1/en not_active Expired - Lifetime
- 2000-05-15 AU AU45973/00A patent/AU775580B2/en not_active Expired
- 2000-05-15 DK DK00927582T patent/DK1185536T3/da active
- 2000-05-15 CN CNB008100829A patent/CN1229382C/zh not_active Expired - Lifetime
- 2000-05-15 SI SI200030599T patent/SI1185536T1/xx unknown
- 2000-05-15 PL PL353002A patent/PL226890B1/pl unknown
- 2000-05-15 BR BRPI0010559A patent/BRPI0010559B8/pt not_active IP Right Cessation
- 2000-05-15 TR TR2001/03273T patent/TR200103273T2/xx unknown
- 2000-05-15 CA CA2372058A patent/CA2372058C/en not_active Expired - Lifetime
- 2000-05-15 NZ NZ515424A patent/NZ515424A/en not_active IP Right Cessation
- 2000-05-15 KR KR1020017014551A patent/KR100834601B1/ko not_active Expired - Lifetime
- 2000-05-15 SK SK1650-2001A patent/SK287835B6/sk not_active IP Right Cessation
- 2000-05-15 HU HU0201188A patent/HU230646B1/hu unknown
- 2000-05-15 DE DE60016209T patent/DE60016209T2/de not_active Expired - Lifetime
- 2000-05-15 ES ES00927582T patent/ES2233367T3/es not_active Expired - Lifetime
2001
- 2001-05-15 WO PCT/GB2001/002120 patent/WO2001087895A1/en not_active Ceased
- 2001-05-15 CN CNB018127460A patent/CN1211386C/zh not_active Expired - Lifetime
- 2001-05-15 US US10/257,856 patent/US20040002602A1/en not_active Abandoned
- 2001-05-15 CZ CZ2002-3751A patent/CZ304973B6/cs not_active IP Right Cessation
- 2001-05-15 CN CNB018120431A patent/CN100475822C/zh not_active Expired - Lifetime
- 2001-05-15 CA CA2406095A patent/CA2406095C/en not_active Expired - Lifetime
- 2001-05-15 SI SI200130399T patent/SI1287004T1/sl unknown
- 2001-05-15 BR BRPI0110801-8 patent/BRPI0110801B8/pt not_active IP Right Cessation
- 2001-05-15 BR BRPI0110443-8 patent/BRPI0110443B8/pt not_active IP Right Cessation
- 2001-05-15 CZ CZ2002-3746A patent/CZ304966B6/cs not_active IP Right Cessation
- 2001-05-15 WO PCT/GB2001/002110 patent/WO2001087894A1/en not_active Ceased
- 2001-05-15 ES ES01929813T patent/ES2231486T3/es not_active Expired - Lifetime
- 2001-05-15 SK SK1527-2002A patent/SK287879B6/sk not_active IP Right Cessation
- 2001-05-15 AU AU5649601A patent/AU5649601A/xx active Pending
- 2001-11-13 NO NO20015547A patent/NO322016B1/no not_active IP Right Cessation
2002
- 2002-10-29 NO NO20025186A patent/NO328301B1/no not_active IP Right Cessation
- 2002-11-20 BG BG107301A patent/BG65896B1/bg unknown
2007
- 2007-07-09 US US11/774,890 patent/US7524956B2/en not_active Expired - Fee Related
- 2007-10-29 CY CY20071101392T patent/CY1108095T1/el unknown

Also Published As

Publication number	Publication date
CN100475822C (zh)	2009-04-08
CA2372058A1 (en)	2000-11-23
SK287879B6 (sk)	2012-02-03
CZ20014102A3 (cs)	2002-06-12
JP2002544280A (ja)	2002-12-24
CA2406095A1 (en)	2001-11-22
CN1211386C (zh)	2005-07-20
WO2001087894A1 (en)	2001-11-22
NO328301B1 (no)	2010-01-25
BR0110801A (pt)	2003-02-11
TR200103273T2 (tr)	2002-04-22
SK16502001A3 (sk)	2002-06-04
BRPI0110801B1 (pt)	2018-02-27
EP1185536A2 (en)	2002-03-13
SI1185536T1 (en)	2005-06-30
NZ515424A (en)	2004-06-25
KR100834601B1 (ko)	2008-06-02
DE60016209T2 (de)	2005-12-15
JP4445136B2 (ja)	2010-04-07
CN1441805A (zh)	2003-09-10
BRPI0110801B8 (pt)	2021-05-25
NO20015547L (no)	2002-01-14
US20080045713A1 (en)	2008-02-21
ES2233367T3 (es)	2005-06-16
RU2237063C9 (ru)	2008-10-10
SK287835B6 (sk)	2011-12-05
BR0110443A (pt)	2003-04-08
MXPA01011631A (es)	2002-07-30
KR20020021636A (ko)	2002-03-21
AU775580B2 (en)	2004-08-05
BG107301A (bg)	2003-07-31
WO2001087895A1 (en)	2001-11-22
CA2372058C (en)	2010-10-26
ES2231486T3 (es)	2005-05-16
BRPI0010559B8 (pt)	2021-05-25
BRPI0110443B8 (pt)	2021-05-25
CZ20023751A3 (en)	2004-05-12
PL226890B1 (pl)	2017-09-29
DK1185536T3 (da)	2005-04-04
CN1360588A (zh)	2002-07-24
WO2000069862A2 (en)	2000-11-23
AU4597300A (en)	2000-12-05
US7241892B1 (en)	2007-07-10
HU230646B1 (hu)	2017-05-29
RU2237063C2 (ru)	2004-09-27
HUP0201188A2 (en)	2002-07-29
CZ304966B6 (cs)	2015-02-18
PL353002A1 (en)	2003-09-22
SI1287004T1 (sl)	2005-12-31
UA75333C2 (uk)	2006-04-17
MY130271A (en)	2007-06-29
PT1185536E (pt)	2005-04-29
HK1047432A1 (en)	2003-02-21
DE60016209D1 (de)	2004-12-30
US20040002602A1 (en)	2004-01-01
CZ303536B6 (cs)	2012-11-21
BR0010559A (pt)	2002-07-02
BRPI0110443B1 (pt)	2018-06-26
NO20025186D0 (no)	2002-10-29
US7524956B2 (en)	2009-04-28
EP1185536B1 (en)	2004-11-24
CZ304973B6 (cs)	2015-02-25
SK15272002A3 (sk)	2003-06-03
AU5649601A (en)	2001-11-26
NO20015547D0 (no)	2001-11-13
BG65896B1 (bg)	2010-04-30
AR035842A1 (es)	2004-07-21
ATE283273T1 (de)	2004-12-15
WO2000069862A3 (en)	2001-03-22
NO322016B1 (no)	2006-08-07
CY1108095T1 (el)	2014-02-12
CA2406095C (en)	2010-02-16
BRPI0010559B1 (pt)	2016-08-30
CN1229382C (zh)	2005-11-30
CZ20023746A3 (cs)	2003-04-16
CN1440414A (zh)	2003-09-03

Publication	Publication Date	Title
NO20025186L (no)	2003-01-14	Fremgangsmåte for syntese av en ecteinascidinforbindelse
NO20015017D0 (no)	2001-10-15	Fremgangsmåte for fremstilling av citalopram
NO20004606D0 (no)	2000-09-15	FremgangsmÕte for fremstilling av epoksider fra olefiner
NO20022209L (no)	2002-05-08	Fremgangsmåte for syntese av molekylsikter
NO20010318D0 (no)	2001-01-19	Fremgangsmåte for fremstilling av Citalopram
NO20013369D0 (no)	2001-07-06	Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20010319D0 (no)	2001-01-19	Fremgangsmåte for fremstilling av Citalopram
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO982624L (no)	1998-06-08	FremgangsmÕte for syntese av benzimidazolforbindelse
ITMI991486A0 (it)	1999-07-06	Processo per la sintesi di citalopram
NO20001387L (no)	2000-03-16	FremgangsmÕte for syntese av kinolinderivater
NO20000965D0 (no)	2000-02-25	Fremgangsmåte for fremstilling av veksthormon-utskillende forbindelser
NO20006279D0 (no)	2000-12-11	Generator for produksjon av fotonantalltilstand
NO20013995L (no)	2001-10-17	Fremgangsmåte for fremstilling av L-sorbose
NO20001896D0 (no)	2000-04-12	Fremgangsmõte for syntese av klorpurinmellomprodukter
NO20022956D0 (no)	2002-06-19	Fremgangsmåte for fremstilling av nitroguanidin
NO20000805L (no)	2000-08-21	FremgangsmÕte for fremstilling av organiske azider
DK1202949T3 (da)	2004-07-19	Fremgangsmåde til fremstilling af acylerede 1,3-dicarbonylforbindelser
NO20012811D0 (no)	2001-06-07	Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20013044D0 (no)	2001-06-19	Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20020327D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20002558D0 (no)	2000-05-18	FremgangsmÕte for fremstilling av findisperse eksplosivstoffer
NO20014451D0 (no)	2001-09-13	Fremgangsmåte for fremstilling av tiazolidinderivater
NO20016281D0 (no)	2001-12-20	Fremgangsmåte for fremstilling av legemiddel- mellomproduktforbindelser

Legal Events

Date	Code	Title	Description
2021-06-07	MK1K	Patent expired